Descriptions and Correlates of Medication Adherence, Attitudes, and Self-Efficacy in Outpatients With Schizophrenia Spectrum Disorders (SSDs)

被引：9

作者：

Beebe, Lora Humphrey ^{[1
]}

Smith, Kathleen ^{[2
]}

Phillips, Chad ^{[3
]}

机构：

[1] Univ Tennessee, Coll Nursing, Knoxville, TN 37996 USA

[2] Tennessee Wesleyan Coll, Knoxville, TN USA

[3] Helen Ross McNabb Ctr, Knoxville, TN USA

来源：

ARCHIVES OF PSYCHIATRIC NURSING | 2016年 / 30卷 / 03期

基金：

美国医疗保健研究与质量局;

关键词：

RATING-SCALE MARS; INFORMED-CONSENT; MENTAL-ILLNESS; NONADHERENCE; THERAPY; INTERVENTION; RELIABILITY; PREVALENCE; VALIDITY; BEHAVIOR;

D O I：

10.1016/j.apnu.2016.01.010

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

The problem of medication adherence in schizophrenia spectrum disorders (SSDs) has challenged researchers and clinicians for decades. Few investigations have examined non-psychiatric adherence in this group. We conducted a descriptive correlational investigation of adherence and related factors in 185 stable outpatients with SSDs. Fifty-seven percent of participants had antipsychotic medication levels within therapeutic range and 42% had levels below therapeutic range. Pill count percentage adherence to antipsychotic medications ranged from 0-100% with a mean of 70% and SD 34.9. Mean non-psychiatric medication adherence ranged from 0 to 100 with a mean of 61% and SD 31.8. The following characteristics were not significantly associated with adherence: age, diagnosis, gender, race, living arrangement, educational level, typical versus atypical antipsychotic medication. Level of symptoms was correlated negatively and significantly with self-reported medication adherence and medication adherence self-efficacy. Our next project will examine the effectiveness of a telephone-delivered intervention designed to support adherence in this group. (C) 2016 Elsevier Inc. All rights reserved.

引用

页码：400 / 405

页数：6

共 39 条

[1] THE THEORY OF PLANNED BEHAVIOR [J].

AJZEN, I .

ORGANIZATIONAL BEHAVIOR AND HUMAN DECISION PROCESSES, 1991, 50 (02) :179-211

[2]

Ajzen I., 1985, ACTION CONTROL, P11, DOI DOI 10.1007/978-3-642-69746-32

[3]

[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787

[4] Effect of a Motivational Intervention on Exercise Behavior in Persons with Schizophrenia Spectrum Disorders [J].

Beebe, Lora Humphrey ;

Smith, Kathy ;

Burk, Renee ;

McIntyre, Kelly ;

Dessieux, Olivera ;

Tavakoli, Abbas ;

Tennison, Clif ;

Velligan, Dawn .

COMMUNITY MENTAL HEALTH JOURNAL, 2011, 47 (06) :628-636

[5] Informed consent to research in persons with schizophrenia spectrum disorders [J].

Beebe, Lora Humphrey ;

Smith, Kathlene .

NURSING ETHICS, 2010, 17 (04) :425-434

[6]

Beebe Lora Humphrey, 2008, J Am Psychiatr Nurses Assoc, V14, P217, DOI 10.1177/1078390308318750

[7]

Bergemann N, 2004, PHARMACOPSYCHIATRY, V37, P63

[8] Decisional capacity for informed consent in schizophrenia research [J].

Carpenter, WT ;

Gold, JM ;

Lahti, AC ;

Queern, CA ;

Conley, RR ;

Bartko, JJ ;

Kovnick, J ;

Appelbaum, PS .

ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (06) :533-538

[9] Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies [J].

Czobor, Pal ;

Van Dorn, Richard A. ;

Citrome, Leslie ;

Kahn, Rene S. ;

Fleischhacker, W. Wolfgang ;

Volavka, Jan .

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (08) :1158-1166

[10] Risperidone dose and blood level variability: Accumulation effects and interindividual and intraindividual variability in the nonresponder patient in the clinical practice setting [J].

Darby, JK ;

Pasta, DJ ;

Elfand, L ;

Dabiri, L ;

Clark, L ;

Herbert, J .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 (06) :478-484

← 1 2 3 4 →